Health authorities and vaccine manufacturers need to find more efficacious, cost-effective vaccines while expediting vaccine development to serve larger populations and meet potential pandemic threats. Plus, they must navigate a variety of regulatory, biosafety and clinical development challenges to meet these demands.
Available on-demand, our Regulatory, Biosafety and Clinical Strategies for Accelerating Vaccine Development webinar explores a range of regulatory, biosafety and clinical strategies for anyone involved in vaccine development. It also addresses vital strategies for the development of seasonal and pandemic influenza vaccines, as well as universal vaccines.
Speakers including, Robert Lins, MD, PhD, Senior Clinical Advisor, Clinical Research, SGS Life Science Services, Archie Lovatt, PhD, Scientific Operations Director, SGS Vitrology and Rajesh K. Gupta, PhD, Principal Consultant Biologics Quality & Regulatory Consultants, LLC, present:
- A clinical expert’s review
- A case study
- A biosafety expert’s review of viral biosafety testing strategies
- A regulatory expert’s perspective on new and evolving vaccine approval trends and challenges
For more information please contact:
75 Passaic Avenue
Fairfield NJ 07004 US
t: +1 888 747 8782